14 tulemused
A 50-year-old housewife with a main complaint of dyspnea was admitted to our hospital in September, 1992. In 1975, the patient developed aphthous stomatitis, genital aphthous ulcers, uveitis and erythema nodosum appeared and diagnosed as having Behcet's disease at Department of Dermatology of our
OBJECTIVE
We sought to determine the prevalence and correlates of aortic regurgitation (AR) in a population-based sample group.
BACKGROUND
Concern over induction of AR by weight loss medication highlights the importance of assessing the prevalence and correlates of AR in unselected patient
The morphologic, biochemical, and mechanical abnormalities of connective tissue fibrous proteins in Marfan's syndrome have been well studied, and their role in cardiovascular complications is well accepted. Less is known, however, about the state of the amorphous components of the aortic connective
Transcatheter aortic valve implantation (TAVI) is approved for treatment of symptomatic aortic stenosis in patients at increased risk for surgical valve replacement, but outcomes data in patients with severe native aortic regurgitation (AR) treated with TAVI remain limited. The objective of this
OBJECTIVE
Concern has been raised regarding the late effects of tissue glues. Herein is described the authors' experience with a new bioadhesive (BioGlue; Cryolife) for repair of the aortic root in acute dissection.
METHODS
BioGlue is composed of bovine serum albumin (BSA) and glutaraldehyde.
S2-gated (the second heart sound) method was designed by authors. In 6 normal subjects and 16 patients (old myocardial infarction 12 cases, hypertension 2 cases and aortic regurgitation 2 cases), radioisotope (RI) angiography using S2-gated equilibrium method was performed. In RI angiography,
Fifty four patients who had aneurysms (n = 35) or dissections (n = 19) associated with aortic regurgitation underwent the replacement of the ascending aorta and aortic valve by composite valve graft during 15-year period between September 1976 and December 1991. Of these, 49 (90.7%) patients had an
Over a period of 18 months, 313 patients (mean age 52 years) undergoing elective cardiovascular surgery were included in the autologous transfusion program involving two different Transfusion Centres. A further 10 patients were excluded because of anaemia (haemoglobin levels less than 11 g.dl-1) (n
OBJECTIVE
To evaluate the early complications during and after transcatheter closure of perimembranous ventricular septal defects (PMVSDs) in children.
METHODS
A total of 223 patients received transcatheter closure of PMVSDs from March 2002 to December 2005 in our hospital were included in this
Transcatheter aortic valve implantation (TAVI) is recommended for patients who are inoperable or at high risk for surgical aortic valve replacement (SAVR). Corticosteroid therapy is considered to be a risk factor for SAVR, but there is a paucity of information about TAVI in patients taking
BACKGROUND
Cardioplegia is used to protect the myocardium from ischemic injury during open-heart surgery. However, the delivery of cardioplegic solutions may be impaired by anatomic and/or functional conditions, such as the development of transient aortic regurgitation during antegrade
A case of partial anomalous pulmonary venous return (PAPVR) associated with mitral stenosis and aortic regurgitation is described. The diagnostic clue was radiocardiography using radioiodide serum albumin (RISA), our routine procedure before cardiac catheterization. The abnormal vessel connected
Mitral and aortic regurgitation was assessed from analysis of activity-time curves from right and left ventricles following the intravenous bolus injection of 99Tcm-labelled human serum albumin. The differences in the initial arrival times and the mean transit times for the ventricles were combined
BACKGROUND
Recent interests have mainly focused on the roles of serum calcium and phosphorus and their product (Ca-P product) in the development of valvular heart disease. The present study assessed the relationship between the Ca-P product and the severity of valvular heart disease in end-stage